G. L. Gleason
- Molecular Biology
- Cancer Research top 5%
- Health, Toxicology and Mutagenesis top 10%
- Oncology
- Pharmacology top 5%
- Co-authors
- Thomas J. SlagaSusan M. FischerJohn DiGiovanniWayne LevinD. M. JERINAAllan H. ConneyHaruhiko YagiRonald G. Harvey
- Topics
- Estrogen and related hormone effects (5 papers)Carcinogens and Genotoxicity Assessment (3 papers)Inflammatory mediators and NSAID effects (3 papers)
- Journals
- Proceedings of the National Academy of SciencesJNCI Journal of the National Cancer InstituteCarcinogenesis
- Partner nations
- United States
In The Last Decade
G. L. Gleason
12 papers receiving 737 citations
Peers
Comparison fields: 5 of 85
- Molecular Biology 482
- Cancer Research 332
- Health, Toxicology and Mutagenesis 129
- Oncology 116
- Pharmacology 88
Countries citing papers authored by G. L. Gleason
This map shows the geographic impact of G. L. Gleason's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. L. Gleason with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. L. Gleason more than expected).
Fields of papers citing papers by G. L. Gleason
This network shows the impact of papers produced by G. L. Gleason. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. L. Gleason. The network helps show where G. L. Gleason may publish in the future.
Co-authorship network of co-authors of G. L. Gleason
This figure shows the co-authorship network connecting the top 25 collaborators of G. L. Gleason. A scholar is included among the top collaborators of G. L. Gleason based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. L. Gleason. G. L. Gleason is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | Prostaglandin enhancement of skin tumor initiation and promotion. | 10 |
| 2 | Time-dependent inhibition by 2,3,7,8-tetrachlorodibenzo-p-dioxin of skin tumorigenesis with polycyclic hydrocarbons. | 28 |
| 3 | 270 | |
| 4 | Comparison of the skin tumor-initiating activities of dihydrodiols and diol-epoxides of various polycyclic aromatic hydrocarbons. | 47 |
| 5 | 31 | |
| 6 | 34 | |
| 7 | Marked differences in the skin tumor-initiating activities of the optical enantiomers of the diastereomeric benzo(a)pyrene 7,8-diol-9,10-epoxides. | 220 |
| 8 | 8 | |
| 9 | 47 | |
| 10 | Potent tumor-initiating activity of the 3,4-dihydrodiol of 7,12-dimethylbenz(a)anthracene in mouse skin. | 73 |
| 11 | 29 | |
| 12 | Lack of tumor-promoting ability of certain environmental chemicals in a two-stage mouse skin tumorigenesis assay. | 27 |
About G. L. Gleason
G. L. Gleason is a scholar working on Pharmacology, Cancer Research and Genetics, having authored 12 papers that have together received 824 indexed citations. Recurring topics across this work include Estrogen and related hormone effects (5 papers), Carcinogens and Genotoxicity Assessment (3 papers) and Inflammatory mediators and NSAID effects (3 papers). The work is most often cited by research in Cancer Research (332 citations), Pharmacology (88 citations) and Health, Toxicology and Mutagenesis (129 citations). G. L. Gleason has collaborated with scholars based in United States. Frequent co-authors include Thomas J. Slaga, Susan M. Fischer, John DiGiovanni, Wayne Levin, D. M. JERINA, Allan H. Conney, Haruhiko Yagi, Ronald G. Harvey, K. B. SUKUMARAN and William M. Bracken. Their work appears in journals such as Proceedings of the National Academy of Sciences, JNCI Journal of the National Cancer Institute and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.